We are live on
!
Find out more
EFMH
E Fund Management (HK) Portfolio holdings
AUM
$302M
1-Year Est. Return
64.42%
This Fund
S&P 500
This Quarter
Est. Return
+37.29%
1 Year Est. Return
+64.42%
3 Year Est. Return
+162.67%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$302M
AUM Growth
+$81.7M
(+37%)
Cap. Flow
+$49.8M
Cap. Flow
% of AUM
16.5%
Top 10 Holdings %
Top 10 Hldgs %
44.29%
Holding
566
New
75
Increased
276
Reduced
70
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.94M |
| 2 |
Apple
AAPL
|
+$2.84M |
| 3 |
NVIDIA
NVDA
|
+$2.39M |
| 4 |
Full Truck Alliance
YMM
|
+$2.36M |
| 5 |
Amazon
AMZN
|
+$2.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$4.76M |
| 2 |
Diana Shipping
DSX
|
+$1.27M |
| 3 |
Corning
GLW
|
+$1.04M |
| 4 |
Newmont
NEM
|
+$809K |
| 5 |
Tower Semiconductor
TSEM
|
+$542K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.52% |
| 2 | Consumer Discretionary | 14.67% |
| 3 | Communication Services | 9.91% |
| 4 | Materials | 4.96% |
| 5 | Consumer Staples | 3.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Arrowhead Research
ARWR
$12.1B
| $27.6K | 0.01% |
338
+97
| +40% | +$7.17K |
|
252
Jazz Pharmaceuticals
JAZZ
$16.1B
| $27.5K | 0.01% |
114
+35
| +44% | +$7.67K |
|
253
Cytokinetics
CYTK
$10.8B
| $27.2K | 0.01% |
319
+80
| +33% | +$5.74K |
|
254
Incyte
INCY
$25.3B
| $27.1K | 0.01% |
239
+50
| +26% | +$4.96K |
|
255
argenx
ARGX
$55.3B
| $26.9K | 0.01% |
29
+9
| +45% | +$7.42K |
|
256
Kymera Therapeutics
KYMR
$8.63B
| $26.7K | 0.01% |
233
+60
| +35% | +$5.16K |
|
257
Colgate-Palmolive
CL
$74.1B
| $26.5K | 0.01% |
289
+174
| +151% | +$15.2K |
|
258
Republic Services
RSG
$68.2B
| $26.4K | 0.01% |
124
+122
| +6,100% | +$25.5K |
|
259
KKR & Co
KKR
$89.8B
| $26.3K | 0.01% |
287
+201
| +234% | +$19.5K |
|
260
Protagonist Therapeutics
PTGX
$8.81B
| $25.9K | 0.01% |
211
+55
| +35% | +$5.75K |
|
261
Valero Energy
VLO
$90.1B
| $25.8K | 0.01% |
99
-1,267
| -93% | -$312K |
|
262
Neurocrine Biosciences
NBIX
$18.3B
| $25.6K | 0.01% |
152
+40
| +36% | +$5.93K |
|
263
Keysight
KEYS
$51.1B
| $25.6K | 0.01% |
+73
| New | +$24.9K |
|
264
Exelixis
EXEL
$14.1B
| $25.4K | 0.01% |
467
+120
| +35% | +$5.84K |
|
265
Madrigal Pharmaceuticals
MDGL
$12.5B
| $25.2K | 0.01% |
47
+14
| +42% | +$7.17K |
|
266
PTC Therapeutics
PTCT
$6.2B
| $25.2K | 0.01% |
309
+80
| +35% | +$5.78K |
|
267
Citizens Financial Group
CFG
$30.6B
| $25.2K | 0.01% |
359
| – | – |
|
|
NVO
268
Novo Nordisk
NVO
$228B
| $25.1K | 0.01% |
524
+150
| +40% | +$6.45K |
|
269
United Therapeutics
UTHR
$25.9B
| $24.9K | 0.01% |
46
+16
| +53% | +$9.01K |
|
270
United Parcel Service
UPS
$89.4B
| $24.7K | 0.01% |
230
+147
| +177% | +$15.3K |
|
271
American Tower
AMT
$81B
| $24.5K | 0.01% |
150
+99
| +194% | +$17.8K |
|
272
W.W. Grainger
GWW
$64.5B
| $24.5K | 0.01% |
+18
| New | +$22.2K |
|
273
UDR
UDR
$12.7B
| $24.5K | 0.01% |
+613
| New | +$22.7K |
|
|
NUVL
274
DELISTED
Nuvalent
NUVL
| $24.1K | 0.01% |
195
+50
| +34% | +$5.38K |
|
275
Erasca
ERAS
$6.03B
| $24K | 0.01% |
1,312
+380
| +41% | +$5.43K |
|
Similar funds
GFG
PWS
TAFW
CLC
M2MC
UWM
AFGI4KRSP
GCC
E Fund Management (HK)'s Q2 2026 Portfolio in Review
As of Q2 2026, E Fund Management (HK) held 566 positions worth $302M, up 37% from $220M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
E Fund Management (HK) deployed $49.8M of net new capital in Q2 2026, opening 75 new positions and adding to 276 existing holdings. Its largest new stake was Full Truck Alliance: 276,764 shares worth $2.25M.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Pinduoduo, an estimated $4.76M trimmed.
- E Fund Management (HK)'s largest Q2 2026 buy was Full Truck Alliance: 276,764 shares worth $2.25M.
- E Fund Management (HK) added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $2.94M increase.
- E Fund Management (HK)'s biggest Q2 2026 reduction was Pinduoduo, cutting an estimated $4.76M.
- E Fund Management (HK) fully exited Diana Shipping in Q2 2026, selling an estimated $1.27M.
- E Fund Management (HK)'s ten largest holdings make up 44% of its $302M portfolio in Q2 2026.
- E Fund Management (HK) opened 75 new positions and closed 17 in Q2 2026.
- E Fund Management (HK)'s portfolio value rose 37% quarter-over-quarter to $302M.
Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.